Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Novus Therapeutics (NVUS) Phase 2a Trial of OP0201 in Acute Otitis Media Did Not Achieve Statistical Significance for Primary Efficacy Endpoints
-
Novus Therapeutics Announces Topline Results of Phase 2a Clinical Trial of OP0201 in Acute Otitis Media
-
Tourmaline Partners Adds Three Senior Executives Amid Continued Growth
-
Scorpio Tankers Inc. Announces Pricing of $25 Million 7.00% Senior Unsecured Notes Due 2025
-
Scorpio Tankers Inc. Announces Public Offering of Senior Unsecured Notes Due 2025
-
Windtree Therapeutics Announces Closing of $23 Million Public Offering Including Full Exercise of Over-Allotment Option
-
Jaguar Health (JAGX) Announces Exercise of Warrants for $4.45 Million Gross Proceeds
-
Jaguar Health Announces Exercise of Warrants for $4.45 Million Gross Proceeds
-
Windtree Therapeutics, Inc. (WINT) Prices 2.758M Unit Common Offering at $7.25/Unit; Announces Uplisting to Nasdaq
-
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
-
PowerFleet (PWFL) PT Lowered to $6 at Ladenburg Thalmann, Following Earnings
-
Form 13F-NT Ladenburg Thalmann Asset For: Mar 31
-
TG Therapeutics (TGTX) Prices 8.5M Share Upsized Common Offering at $18/Sh
-
Independent Broker-Dealer Recruiter Jon Henschen Publishes Commentary on ThinkAdvisor.com, "Ex-Ladenburg BDs May Face Culture Clash"
-
TG Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Novavax (NVAX) PT Raised to $38 at Ladenburg Thalmann
-
S&P 500 tumbles on fears of virus resurgence in economic reopening
-
Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates
-
CORRECTING and REPLACING Vector Group Reports First Quarter 2020 Financial Results
-
Vector Group Reports First Quarter 2020 Financial Results
-
Ladenburg Thalmann Starts Usio Inc. (USIO) at Buy
-
Saratoga Investment Corp. Announces Fiscal Year-End and Fourth Quarter 2020 Financial Results
-
Marinus Pharmaceuticals (MRNS) PT Lowered to $4.50 at Ladenburg Thalmann, Following Earnings
-
CHF Solutions Inc. (CHFS) Prices Direct Offering of 3.6M Shares at $0.4725
-
CHF Solutions, Inc. Announces Registered Direct Offering Priced At-the-Market
-
Advisor Group Announces Expansion Of Coronavirus Response Resource Center To Support Financial Professionals During Unprecedented Conditions
-
Form 10-K/A LADENBURG THALMANN FINAN For: Dec 31
-
Avadel Pharma (AVDL) Prices 11.63M ADS Offering at $10.75/ADS
-
Avadel Pharmaceuticals Announces Pricing of Public Offering
-
MTBC Completes Its Offering of Non-Convertible Preferred Stock with $20.7 Million in Gross Proceeds
-
MTBC Completes Its Offering of Non-Convertible Preferred Stock with $20.7 Million in Gross Proceeds
-
Axsome Therapeutics (AXSM) PT Raised to $186 at Ladenburg Thalmann, After Company Announces AXS-05 Drug Achieves Primary Endpoint in the ADVANCE-1 Pivotal Phase 2/3 Trial In Alzheimer’s Disease Agit
-
Ladenburg Thalmann Starts Salarius Pharmaceuticals (SLRX) at Buy
-
Cyclacel Announces Closing of $20 Million Public Offering
-
Cyclacel Announces Closing of $20 Million Public Offering
-
MTBC Announces Upsizing and Pricing of $18.0 Million Public Offering of Preferred Stock
-
MTBC Announces Upsizing and Pricing of $18.0 Million Public Offering of Preferred Stock
-
MTBC Announces Commencement of Public Offering of Preferred Stock
-
MTBC Announces Commencement of Public Offering of Preferred Stock
-
Cyclacel Pharma (CYCC) Prices $20M Offering of Common Stock, Warrants
-
CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
-
CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
-
Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Ladenburg Thalmann Starts Benitec BioPharma (BNTC) at Buy
-
Viveve Medical (VIVE) Announces Exercise of Warrants for $3 Million Gross Proceeds
-
Viveve Announces Exercise of Warrants for $3 Million Gross Proceeds
-
LiveXLive Media (LIVX) PT Raised to $3.50 at Ladenburg Thalmann, After Comany Annnounces Partnership With Facebook's Oculus Venues (NASDAQ: FB) And Complex Media
-
Arcturus Therapeutics (ARCT) Prices 4.12M Share Common Stock Offering at $17/sh
-
Arcturus Therapeutics Announces Pricing of $70.0 Million Public Offering of Common Stock
-
UPDATE: Ladenburg Thalmann Downgrades Chesapeake Energy (CHK) to Sell

